MA39025A1 - Pipéridyl-éthyl-pyrimidine substituée utilisée comme inhibiteur de la ghréline o-acyl transférase - Google Patents
Pipéridyl-éthyl-pyrimidine substituée utilisée comme inhibiteur de la ghréline o-acyl transféraseInfo
- Publication number
- MA39025A1 MA39025A1 MA39025A MA39025A MA39025A1 MA 39025 A1 MA39025 A1 MA 39025A1 MA 39025 A MA39025 A MA 39025A MA 39025 A MA39025 A MA 39025A MA 39025 A1 MA39025 A1 MA 39025A1
- Authority
- MA
- Morocco
- Prior art keywords
- ghrelin
- piperidyl
- inhibitor
- ethyl
- acyl transferase
- Prior art date
Links
- 102100038752 Ghrelin O-acyltransferase Human genes 0.000 title abstract 2
- 101710205760 Ghrelin O-acyltransferase Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- OZVCZTSNWCUNQA-UHFFFAOYSA-N 2-ethyl-4-piperidin-1-ylpyrimidine Chemical group CCC1=NC=CC(N2CCCCC2)=N1 OZVCZTSNWCUNQA-UHFFFAOYSA-N 0.000 title 1
- 241000283707 Capra Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne de nouveaux inhibiteurs de la ghréline o-acyl transférase (goat) et leurs sels et des compositions pharmaceutiques de ceux-ci.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382460 | 2013-11-14 | ||
| PCT/US2014/064202 WO2015073281A1 (fr) | 2013-11-14 | 2014-11-06 | Pipéridyl-éthyl-pyrimidine substituée utilisée comme inhibiteur de la ghréline o-acyl transférase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA39025A1 true MA39025A1 (fr) | 2017-05-31 |
| MA39025B1 MA39025B1 (fr) | 2018-05-31 |
Family
ID=49622771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39025A MA39025B1 (fr) | 2013-11-14 | 2014-11-06 | Pipéridyl-éthyl-pyrimidine substituée utilisée comme inhibiteur de la ghréline o-acyl transférase |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US9035051B1 (fr) |
| EP (1) | EP3068775B1 (fr) |
| JP (1) | JP6159484B2 (fr) |
| KR (1) | KR101739243B1 (fr) |
| CN (1) | CN105636948B (fr) |
| AP (1) | AP2016009189A0 (fr) |
| AR (1) | AR098274A1 (fr) |
| AU (1) | AU2014348967B2 (fr) |
| BR (1) | BR112016009488B1 (fr) |
| CA (1) | CA2926224C (fr) |
| CL (1) | CL2016001023A1 (fr) |
| CR (1) | CR20160184A (fr) |
| CY (1) | CY1119489T1 (fr) |
| DK (1) | DK3068775T3 (fr) |
| DO (1) | DOP2016000070A (fr) |
| EA (1) | EA028550B1 (fr) |
| ES (1) | ES2647790T3 (fr) |
| HR (1) | HRP20171648T1 (fr) |
| HU (1) | HUE035590T2 (fr) |
| IL (1) | IL244856A (fr) |
| JO (1) | JO3302B1 (fr) |
| LT (1) | LT3068775T (fr) |
| MA (1) | MA39025B1 (fr) |
| ME (1) | ME02841B (fr) |
| MX (1) | MX2016006223A (fr) |
| NO (1) | NO3068775T3 (fr) |
| NZ (1) | NZ718373A (fr) |
| PE (1) | PE20160609A1 (fr) |
| PH (1) | PH12016500895B1 (fr) |
| PL (1) | PL3068775T3 (fr) |
| PT (1) | PT3068775T (fr) |
| RS (1) | RS56533B1 (fr) |
| SG (1) | SG11201602953YA (fr) |
| SI (1) | SI3068775T1 (fr) |
| TN (1) | TN2016000145A1 (fr) |
| TW (1) | TWI538677B (fr) |
| UA (1) | UA118034C2 (fr) |
| WO (1) | WO2015073281A1 (fr) |
| ZA (1) | ZA201602202B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR104673A1 (es) * | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| AR104672A1 (es) * | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| LT3494120T (lt) * | 2016-08-05 | 2021-05-25 | Boehringer Ingelheim International Gmbh | Oksadiazolopiridino dariniai, skirti naudoti kaip grelino o-aciltransferazės (goat) inhibitoriai |
| CN106478519B (zh) * | 2016-10-10 | 2018-12-11 | 上海再启生物技术有限公司 | 一种2-甲基-4-氨基-6-氯嘧啶的制备方法 |
| WO2019149657A1 (fr) * | 2018-02-02 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Dérivés d'oxadiazolopyridine à substitution benzyle, (pyridin-3-yl)méthyle ou (pyridin-4-yl)méthyle utilisés en tant qu'inhibiteurs de la ghréline o-acyltransférase (goat) |
| US11136337B2 (en) | 2018-02-02 | 2021-10-05 | Boehringer Ingelheim International Gmbh | Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors |
| EA202091804A1 (ru) * | 2018-02-02 | 2020-12-24 | Бёрингер Ингельхайм Интернациональ Гмбх | Гетероциклил-замещенные оксадиазолопиридиновые производные для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) |
| EA202091803A1 (ru) | 2018-02-02 | 2020-12-16 | Бёрингер Ингельхайм Интернациональ Гмбх | Производные триазолопиримидина для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) |
| CN108558852A (zh) * | 2018-05-30 | 2018-09-21 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108558849A (zh) * | 2018-05-30 | 2018-09-21 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN108516971A (zh) * | 2018-05-30 | 2018-09-11 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN108774221A (zh) * | 2018-05-30 | 2018-11-09 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108610337A (zh) * | 2018-05-30 | 2018-10-02 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| BR112022017039A2 (pt) | 2020-02-28 | 2022-11-16 | Kallyope Inc | Agonistas de gpr40 |
| CN115916789B (zh) | 2020-05-22 | 2025-06-27 | 勃林格殷格翰国际有限公司 | 制备烷基7-氨基-5-甲基-[1,2,5]噁二唑并[3,4-b]吡啶羧酸酯的连续方法 |
| HUE066997T2 (hu) | 2020-05-22 | 2024-09-28 | Boehringer Ingelheim Int | Eljárás alkil-7-amino-5-metil-[1,2,5]oxidiazol[3,4-B]piridin-karboxilát elõállítására |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1268449A4 (fr) * | 2000-03-23 | 2004-09-15 | Merck & Co Inc | Piperidines substituees en tant qu'agonistes du recepteur de la melanocortine |
| EP1670827A2 (fr) | 2003-09-05 | 2006-06-21 | Eli Lilly And Company | Anticorps anti-ghreline |
| US20070237775A1 (en) | 2004-07-14 | 2007-10-11 | Eli Lilly And Company | Anti-Ghrelin Antibodies |
| EP1814916A2 (fr) | 2004-11-15 | 2007-08-08 | Eli Lilly And Company | Anticorps de desacyle ghreline et utilisations therapeutiques de ceux-ci |
| US7479271B2 (en) | 2005-02-23 | 2009-01-20 | Eli Lilly And Company | Humanized anti-ghrelin antibodies |
| CN101175759A (zh) * | 2005-05-17 | 2008-05-07 | 先灵公司 | 作为治疗血脂异常的烟酸受体激动剂的杂环化合物 |
| KR20080016567A (ko) * | 2005-05-17 | 2008-02-21 | 쉐링 코포레이션 | 지질혈증장애의 치료를 위한 니코틴산 수용체 효능제로서의헤테로사이클 |
| US20070213359A1 (en) * | 2005-12-30 | 2007-09-13 | Acadia Pharmaceuticals Inc. | Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| EP2268143A4 (fr) * | 2008-03-20 | 2012-06-27 | Forest Lab Holdings Ltd | Nouveaux dérivés de pipéridine servant d'inhibiteurs de stéaroyle-coa-désaturase |
| AR091516A1 (es) * | 2012-06-22 | 2015-02-11 | Actelion Pharmaceuticals Ltd | Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida |
-
2014
- 2014-06-11 UA UAA201604765A patent/UA118034C2/uk unknown
- 2014-10-30 JO JOP/2014/0316A patent/JO3302B1/ar active
- 2014-10-31 TW TW103137938A patent/TWI538677B/zh active
- 2014-11-03 AR ARP140104111A patent/AR098274A1/es unknown
- 2014-11-06 AP AP2016009189A patent/AP2016009189A0/en unknown
- 2014-11-06 PT PT148027550T patent/PT3068775T/pt unknown
- 2014-11-06 NO NO14802755A patent/NO3068775T3/no unknown
- 2014-11-06 TN TN2016000145A patent/TN2016000145A1/en unknown
- 2014-11-06 AU AU2014348967A patent/AU2014348967B2/en active Active
- 2014-11-06 NZ NZ718373A patent/NZ718373A/en unknown
- 2014-11-06 DK DK14802755.0T patent/DK3068775T3/en active
- 2014-11-06 SG SG11201602953YA patent/SG11201602953YA/en unknown
- 2014-11-06 BR BR112016009488-3A patent/BR112016009488B1/pt active IP Right Grant
- 2014-11-06 CN CN201480058584.6A patent/CN105636948B/zh active Active
- 2014-11-06 HU HUE14802755A patent/HUE035590T2/en unknown
- 2014-11-06 WO PCT/US2014/064202 patent/WO2015073281A1/fr not_active Ceased
- 2014-11-06 HR HRP20171648TT patent/HRP20171648T1/hr unknown
- 2014-11-06 MX MX2016006223A patent/MX2016006223A/es active IP Right Grant
- 2014-11-06 EA EA201690764A patent/EA028550B1/ru not_active IP Right Cessation
- 2014-11-06 PE PE2016000620A patent/PE20160609A1/es active IP Right Grant
- 2014-11-06 RS RS20171067A patent/RS56533B1/sr unknown
- 2014-11-06 MA MA39025A patent/MA39025B1/fr unknown
- 2014-11-06 LT LTEP14802755.0T patent/LT3068775T/lt unknown
- 2014-11-06 US US14/534,212 patent/US9035051B1/en active Active
- 2014-11-06 ES ES14802755.0T patent/ES2647790T3/es active Active
- 2014-11-06 EP EP14802755.0A patent/EP3068775B1/fr active Active
- 2014-11-06 PL PL14802755T patent/PL3068775T3/pl unknown
- 2014-11-06 JP JP2016531705A patent/JP6159484B2/ja active Active
- 2014-11-06 SI SI201430379T patent/SI3068775T1/sl unknown
- 2014-11-06 CA CA2926224A patent/CA2926224C/fr active Active
- 2014-11-06 KR KR1020167012340A patent/KR101739243B1/ko active Active
- 2014-11-06 ME MEP-2017-224A patent/ME02841B/fr unknown
-
2016
- 2016-03-29 DO DO2016000070A patent/DOP2016000070A/es unknown
- 2016-04-03 IL IL244856A patent/IL244856A/en active IP Right Grant
- 2016-04-04 ZA ZA201602202A patent/ZA201602202B/en unknown
- 2016-04-21 CR CR20160184A patent/CR20160184A/es unknown
- 2016-04-29 CL CL2016001023A patent/CL2016001023A1/es unknown
- 2016-05-13 PH PH12016500895A patent/PH12016500895B1/en unknown
-
2017
- 2017-10-20 CY CY20171101093T patent/CY1119489T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39025A1 (fr) | Pipéridyl-éthyl-pyrimidine substituée utilisée comme inhibiteur de la ghréline o-acyl transférase | |
| JOP20200122A1 (ar) | مركبات مفيدة لتثبيط cdk7 | |
| MX2018001990A (es) | Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac. | |
| MX373123B (es) | Derivados deuterados de ruxolitinib. | |
| MX2018013983A (es) | Inhibidores g12c de kras. | |
| GEAP202015005A (en) | Diacylglycerol acyltransferase 2 inhibitors | |
| MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
| EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
| PH12017502051A1 (en) | TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF | |
| JO3450B1 (ar) | أشكال جرعات تحرير جديدة معدلة لمثبطات زانثين اوكسيدوريدوكتيز أو مثبطات زانثين اوكسيديز | |
| MX380250B (es) | Compuestos farmacéuticos inhibidores de cinasa chk-1. | |
| TR201908247T4 (tr) | Sodyum glikoz birlikte taşıyıcı 1 inhibitörleri. | |
| CY1112077T1 (el) | Θεραπεια με πιρφενιδονη αποφευγοντας την φλουβοξαμινη | |
| SA519410093B1 (ar) | مركبات بيريميدو بيريميدينون مفيدة كمثبطات دبليو إى إى-1 كيناز | |
| EA201500801A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
| EA201890331A1 (ru) | Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена | |
| JOP20190262B1 (ar) | مثبطات بيرازول magl | |
| MX373320B (es) | Compuestos inhibidores de pde2. | |
| EA201500851A1 (ru) | ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3) | |
| EA201590787A1 (ru) | Замещенные пиридопиразины в качестве ингибиторов syk | |
| MA42776B1 (fr) | Composés utiles pour l'inhibition du ror-gamma-t | |
| EA201690561A1 (ru) | Пептидилнитрильные соединения в качестве ингибиторов дипептидилпептидазы i | |
| EA201791992A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
| BR112017018342A2 (pt) | inibidores de grelina o-acil transferase | |
| MA39824A (fr) | Composés azole amido-substitués |